![methyl (2R)-2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]butanoate in PDB entry 5o3a, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/5o3a_entity_2_side_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>5o3a</span> contains 1 copy of <span class='highlight'>methyl (2R)-2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]butanoate</span>. Side view.")
![methyl (2R)-2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]butanoate in PDB entry 5o3a, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/5o3a_entity_2_top_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>5o3a</span> contains 1 copy of <span class='highlight'>methyl (2R)-2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]butanoate</span>. Top view.")
Environment details NEW
31P 501 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.